Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
110 hedge funds and large institutions have $51.5M invested in Ampio Pharmaceuticals Inc. in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 9 closing their positions.
215% more call options, than puts
Call options by funds: $2.19M | Put options by funds: $695K
133% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 15
100% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 9
29% more capital invested
Capital invested by funds: $40M → $51.5M (+$11.5M)
7% more funds holding
Funds holding: 103 → 110 (+7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.81M |
| 2 |
WIC
Willis Investment Counsel
Gainesville,
Georgia
|
+$1.63M |
| 3 |
HF
HRT Financial
New York
|
+$855K |
| 4 |
BlackRock
New York
|
+$774K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$756K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$286K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$257K |
| 3 |
Capstone Investment Advisors
New York
|
-$201K |
| 4 |
Jane Street
New York
|
-$135K |
| 5 |
MFS
Mirabella Financial Services
London,
United Kingdom
|
-$107K |
AMPE Hedge Fund Activity: Q1 2021 in Review
110 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2021, worth a combined $51.5M — up 29% from $40M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new AMPE positions and 9 closed out — a net gain of 9 holders — while 35 added to existing stakes and 15 trimmed.
The largest buyer was Millennium Management, adding an estimated $2.81M. The largest seller was Group One Trading, cutting an estimated $286K.
- 110 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2021, up from 103 in Q4 2020.
- Funds reported $51.5M of Ampio Pharmaceuticals Inc. stock for Q1 2021, up 29% quarter-over-quarter.
- 18 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2021 and 9 closed out, a net change of +9 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q1 2021 was Millennium Management, an estimated $2.81M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q1 2021 was Group One Trading, an estimated $286K sold.
Based on aggregated 13F filings for Q1 2021.